This is a type of purpura caused by low platelets, but the exact reason isn't known. It's usually caused by the immune system attacking platelets. It can happen suddenly (in children) or slowly (in adults). It's also called Immune Thrombocytopenia.
Every report comes from a Lived member, sent anonymously.
Have you tried Prednisone for Idiopathic Thrombocytopenic Purpura (ITP)?
Immune thrombocytopenia (ITP), long known as idiopathic thrombocytopenic purpura, is an autoimmune condition in which the immune system mistakenly destroys platelets. Platelets are tiny blood cells that clump together to plug a damaged blood vessel, so when there are too few of them, bleeding starts more easily and takes longer to stop. The immune attack can also slow how many new platelets the bone marrow makes. Many people with ITP have no symptoms, and the low count is found on a routine blood test. When symptoms do appear, they usually involve the skin and the lining of the nose and mouth: easy bruising, purple patches called purpura, tiny flat red dots called petechiae (often on the lower legs), nosebleeds, bleeding gums or unusually heavy periods. Serious internal bleeding is uncommon. Many adults also describe fatigue that affects work and daily life, even when bleeding is not a problem. ITP looks different in children and adults. In children it often follows a viral illness and usually goes away within months. In adults it more often lasts a year or longer.
In ITP, the immune system makes antibodies that attach to the person's own platelets. The spleen and other tissues then remove these tagged platelets from circulation faster than the bone marrow can replace them. Why the immune system targets platelets is not known, which is where the older word idiopathic (of unknown cause) came from. Some things can set off or accompany the process. In children, ITP often follows a viral infection, and rarely the measles-mumps-rubella (MMR) vaccine. In adults, it can follow an infection or certain medicines, or appear during pregnancy. When ITP occurs alongside another condition, such as lupus, common variable immunodeficiency (an immune system disorder), HIV, hepatitis B or C, or chronic lymphocytic leukemia (a slow-growing blood cancer), it is called secondary ITP, and treating that condition can be part of treating the low platelet count. Before adolescence boys and girls are affected about equally; between adolescence and about age 60 it is more common in women. ITP is not caused by anything a person did, and it cannot be prevented.
There is no single test that proves ITP. A clinician diagnoses it by finding a low platelet count and then ruling out other explanations. The assessment includes questions about bleeding, recent infections, medicines and family history, along with an exam for bruising, petechiae and other signs of bleeding. The key test is a complete blood count, which measures platelets along with red and white blood cells. A typical platelet count is roughly 150,000 to 400,000 per microliter of blood, depending on the laboratory. ITP is considered when the count is below 100,000 with no other cause found. Counts between 100,000 and 150,000 are common and have many possible causes. Serious bleeding usually does not occur until the count falls below about 50,000, and often lower. A blood smear, in which a specialist looks at the platelets under a microscope, helps exclude other blood disorders. Depending on the situation, testing may also look for HIV, hepatitis C, the stomach bacterium Helicobacter pylori or other autoimmune conditions. A bone marrow test is not routine, but may be done when the picture is unusual or treatment is not working, to make sure another platelet disorder is not being missed. Platelet antibody tests are not used to confirm the diagnosis.
Treatment aims to prevent serious bleeding and keep the platelet count at a safe level, not to restore a normal number. Many children, and some adults with mild ITP and little bleeding, need only monitoring with repeat blood counts. Decisions about treatment weigh the platelet count, any bleeding, age, other medicines, occupation and activities, and the side effects of each option, so shared decision-making with a hematologist (a blood specialist) is central. Corticosteroids such as prednisone or dexamethasone are the usual first treatment. They calm the immune attack and often raise the count, but they have many side effects, especially with longer use, and counts often fall again when they stop. Specialists therefore try to keep courses short, ideally under six weeks. For adults, current American Society of Hematology guidance suggests that many may be offered rituximab or a platelet-stimulating medicine together with steroids from the start, rather than steroids alone. Intravenous immunoglobulin (IVIG), an infusion of antibodies pooled from donors, is added when steroids are not enough or bleeding is severe. It can raise the count for a few weeks but rarely produces a lasting remission. When ITP persists or returns, the main options are: Thrombopoietin receptor agonists (TPO-RAs) mimic the body's own signal for making platelets. Eltrombopag (Promacta) and avatrombopag (Doptelet) are daily tablets; romiplostim (Nplate) is a weekly injection under the skin. Many people respond and stay in a safe range while taking them, and some can eventually stop. They usually need to be taken long term, and eltrombopag has to be timed apart from dairy, calcium-rich foods, antacids and mineral supplements. Rituximab is an antibody infusion given over a few weeks that targets the immune cells making platelet antibodies. About half of people respond at first, though the response is not always lasting. Fostamatinib (Tavalisse), which helps prevent platelets from being destroyed, and rilzabrutinib (Wayrilz), a newer medicine that dampens the immune signaling that leads to platelet destruction, are tablets approved for adults whose ITP did not respond well enough to an earlier treatment. Surgery to remove the spleen (splenectomy) raises the count in most people and gives lasting remission in many. Because it permanently increases the risk of serious infections and adds a small risk of blood clots, it is usually delayed for at least a year after diagnosis and requires vaccinations beforehand. Platelet transfusions are reserved for emergencies, because transfused platelets are destroyed quickly. If ITP is linked to another condition, such as Helicobacter pylori or hepatitis C infection, treating that condition may help.
The course depends heavily on age. About 8 in 10 children recover within a year, often within weeks or months, and most never have it again. In adults, ITP more often becomes long term: it is called persistent from 3 to 12 months and chronic after 12 months. Even so, chronic ITP varies widely, people with it can live for decades, and many reach a point where they can stop treatment and keep a safe count. Relapses can happen, sometimes after a long symptom-free stretch. Daily life is mostly about lowering bleeding risk. Aspirin, ibuprofen and blood thinners such as warfarin interfere with platelets or clotting, so check with the care team before taking any of them, and read over-the-counter labels, since many products contain aspirin or ibuprofen. Tell any dentist or surgeon about ITP before procedures. Contact sports such as football or boxing, and activities like skiing or horseback riding, carry more bleeding risk when counts are low; how much to limit them depends on the count and should be agreed with the hematologist. Good oral hygiene helps reduce gum bleeding. Follow-up means regular blood counts, more often during treatment changes. Fatigue and the uncertainty of fluctuating counts can be as hard as the bleeding, and support groups such as the Platelet Disorder Support Association connect people with others living with ITP. Pregnancy can lower the platelet count further, so people with ITP who become pregnant are monitored closely by a hematologist and a high-risk pregnancy team, and some need treatment before delivery.
See a clinician if you notice bruising without a clear reason, clusters of tiny red or purple dots on the skin, frequent nosebleeds or bleeding gums, or periods that are much heavier than usual. If you already have ITP, contact your care team about new or increasing bruising and petechiae, or side effects from treatment. Call your care team right away for blood in your urine, black or bloody stools, vomit containing blood or material that looks like coffee grounds, or a nosebleed that keeps returning. If you have had your spleen removed, contact your care team the same day for any fever, because infections without a spleen can become overwhelming within hours; seek emergency care if you cannot reach them and feel very unwell. Call 911 or go to the emergency room for severe bleeding, bleeding that does not stop with firm pressure, or signs of possible bleeding in the brain: a sudden severe headache, confusion, unusual sleepiness, repeated vomiting, weakness, or changes in vision or speech, especially after a head injury while your count is low.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Idiopathic Thrombocytopenic Purpura (ITP) is like, what's helped you, or ask the community a question.